These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 9248697

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Regulation of cap-dependent translation by insulin-like growth factor-1 in neuronal cells.
    Quevedo C, Salinas M, Alcázar A.
    Biochem Biophys Res Commun; 2002 Mar 01; 291(3):560-6. PubMed ID: 11855825
    [Abstract] [Full Text] [Related]

  • 26. Stimulation of protein synthesis, eukaryotic translation initiation factor 4E phosphorylation, and PHAS-I phosphorylation by insulin requires insulin receptor substrate 1 and phosphatidylinositol 3-kinase.
    Mèndez R, Myers MG, White MF, Rhoads RE.
    Mol Cell Biol; 1996 Jun 01; 16(6):2857-64. PubMed ID: 8649395
    [Abstract] [Full Text] [Related]

  • 27. Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation.
    Beretta L, Gingras AC, Svitkin YV, Hall MN, Sonenberg N.
    EMBO J; 1996 Feb 01; 15(3):658-64. PubMed ID: 8599949
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Rapamycin-resistant phosphorylation of the initiation factor-4E-binding protein (4E-BP1) in v-SRC-transformed hamster fibroblasts.
    Tuhácková Z, Sovová V, Sloncová E, Proud CG.
    Int J Cancer; 1999 Jun 11; 81(6):963-9. PubMed ID: 10362146
    [Abstract] [Full Text] [Related]

  • 30. Involvement of stress-activated protein kinase and p38/RK mitogen-activated protein kinase signaling pathways in the enhanced phosphorylation of initiation factor 4E in NIH 3T3 cells.
    Morley SJ, McKendrick L.
    J Biol Chem; 1997 Jul 11; 272(28):17887-93. PubMed ID: 9211946
    [Abstract] [Full Text] [Related]

  • 31. Role of mTOR in the degradation of IRS-1: regulation of PP2A activity.
    Hartley D, Cooper GM.
    J Cell Biochem; 2002 Jul 11; 85(2):304-14. PubMed ID: 11948686
    [Abstract] [Full Text] [Related]

  • 32. Insulin and diabetes cause reciprocal changes in the association of eIF-4E and PHAS-I in rat skeletal muscle.
    Kimball SR, Jefferson LS, Fadden P, Haystead TA, Lawrence JC.
    Am J Physiol; 1996 Feb 11; 270(2 Pt 1):C705-9. PubMed ID: 8779938
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Insulin fails to stimulate muscle protein synthesis in sepsis despite unimpaired signaling to 4E-BP1 and S6K1.
    Vary TC, Jefferson LS, Kimball SR.
    Am J Physiol Endocrinol Metab; 2001 Nov 11; 281(5):E1045-53. PubMed ID: 11595662
    [Abstract] [Full Text] [Related]

  • 35. Distinct repression of translation by wortmannin and rapamycin.
    Pedersen S, Celis JE, Nielsen J, Christiansen J, Nielsen FC.
    Eur J Biochem; 1997 Jul 01; 247(1):449-56. PubMed ID: 9249059
    [Abstract] [Full Text] [Related]

  • 36. Branched-chain amino acids are essential in the regulation of PHAS-I and p70 S6 kinase by pancreatic beta-cells. A possible role in protein translation and mitogenic signaling.
    Xu G, Kwon G, Marshall CA, Lin TA, Lawrence JC, McDaniel ML.
    J Biol Chem; 1998 Oct 23; 273(43):28178-84. PubMed ID: 9774438
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability.
    Beugnet A, Tee AR, Taylor PM, Proud CG.
    Biochem J; 2003 Jun 01; 372(Pt 2):555-66. PubMed ID: 12611592
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002.
    Brunn GJ, Williams J, Sabers C, Wiederrecht G, Lawrence JC, Abraham RT.
    EMBO J; 1996 Oct 01; 15(19):5256-67. PubMed ID: 8895571
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.